» Articles » PMID: 38409315

Nutrient Patterns in Relation to Metabolic Health Status and Serum Levels of Brain-derived Neurotrophic Factor (BDNF) and Adropin in Adults

Overview
Journal Sci Rep
Specialty Science
Date 2024 Feb 26
PMID 38409315
Authors
Affiliations
Soon will be listed here.
Abstract

The present study aimed to investigate the association of nutrient patterns (NPs) with metabolic health status and serum levels of brain-derived neurotrophic factor (BDNF) and adropin in Iranian adults. This cross-sectional survey was performed on 527 adults aged 20-60 years in Isfahan, Iran. To evaluate dietary intake, a validated 168-item semi-quantitative food frequency questionnaire (FFQ) was used. Participants were categorized as metabolically healthy (MH) and metabolically unhealthy (MU) according to their glycemic and lipid profile, insulin resistance (IR), and inflammation status. An overnight fasting blood sample was collected from each participant and serum levels of BDNF and adropin were assessed. A total of 42.50% of participants were recognized as MU. Three NPs were recognized by factor analysis that labeled as "high animal protein" (NP1), "high vegetable" (NP2), and "high carbohydrate" (NP3) patterns. Moderate adherence to NP2 was related to a lower risk of MU (OR = 0.38, 95% CI: 0.18-0.76). Moreover, high adherence of NP2 (T3 vs. T1) was inversely associated with hypertriglyceridemia (OR = 0.27, 95% CI: 0.11-0.65; P-trend < 0.001) and high hs-CRP values (OR = 0.29, 95% CI: 0.09-1.00; P-trend = 0.03). No significant association was observed between adherence of NP1 and NP3 with MU in crude and adjusted models. However, negative associations were found between moderate adherence to NP3 and insulin resistance (IR) (OR = 0.23, 95% CI: 0.06-0.91) as well as high adherence to NP1 and hypertension (OR = 0.23, 95% CI: 0.09-0.61; P-trend < 0.001). NPs were not associated with serum BDNF and adropin values.

Citing Articles

The association between blood selenium and metabolic syndrome in adults: a systematic review and dose-response meta-analysis of epidemiologic studies.

Hajhashemy Z, Foshati S, Bagherniya M, Askari G Front Nutr. 2025; 11:1451342.

PMID: 39882034 PMC: 11775477. DOI: 10.3389/fnut.2024.1451342.

References
1.
Esmailnasab N, Moradi G, Delaveri A . Risk factors of non-communicable diseases and metabolic syndrome. Iran J Public Health. 2012; 41(7):77-85. PMC: 3469019. View

2.
Micha R, Mozaffarian D . Trans fatty acids: effects on metabolic syndrome, heart disease and diabetes. Nat Rev Endocrinol. 2009; 5(6):335-44. DOI: 10.1038/nrendo.2009.79. View

3.
Tucker L . Fiber Intake and Insulin Resistance in 6374 Adults: The Role of Abdominal Obesity. Nutrients. 2018; 10(2). PMC: 5852813. DOI: 10.3390/nu10020237. View

4.
Kim D, Xun P, Liu K, Loria C, Yokota K, Jacobs Jr D . Magnesium intake in relation to systemic inflammation, insulin resistance, and the incidence of diabetes. Diabetes Care. 2010; 33(12):2604-10. PMC: 2992198. DOI: 10.2337/dc10-0994. View

5.
Elder S, Lichtenstein A, Pittas A, Roberts S, Fuss P, Greenberg A . Genetic and environmental influences on factors associated with cardiovascular disease and the metabolic syndrome. J Lipid Res. 2009; 50(9):1917-26. PMC: 2724778. DOI: 10.1194/jlr.P900033-JLR200. View